XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Defines the base value in index calculation and explains its role as the reference point for all subsequent index levels.
21,618 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
The FBI raised a terrorism alert Saturday as U.S.-led strikes on Iran sparked regional retaliation possibilities. Mar...
Start your week with a curated set of monday reads that translate headlines into practical investing moves. This guid...
The VIX slid as optimism about geopolitical peace and cheaper oil spurred a broad market rally. Analysts caution the ...
Putin addresses Zelensky ‘mister’ in a rare tone shift, a move Morgan Stanley calls a vibe shift in peace talks. Mark...
In a speculative timeline, Kevin Warsh is named Federal Reserve Chair, prompting a rethink of policy amid AI-driven g...
A SpaceX IPO could shake up both traditional markets and crypto. This guide explains what spacex coming soon. what me...
Caterpillar’s stock hits milestone as a broad industrials rally lifts Wall Street, sending CAT above the $1,000 thres...
In 2026, dividend aristocrats quietly outrunning software stocks has drawn fresh money into income-focused ETFs as vo...
Investors face a 28% price return gap between XYLD and SPY as income-focused strategy meets growth potential. This re...
Over five years, SPDR’s XLK delivered a 35-point edge on the S&P 500, even as a Feb 2026 pullback tested investor ner...
Bitcoin has fallen about 50% from its October peak as global liquidity rose. Some analysts say bitcoin dumped when gl...